


| Key | % Net Assets |
|---|---|
| 7.8% | |
| 5.1% | |
| 4.8% | |
| 3.7% | |
| 78.6% |
| Name | % Net Assets |
|---|---|
| BP | 7.8% |
| GlaxoSmithKline | 5.1% |
| Royal Dutch Shell A | 4.8% |
| Royal Dutch Shell B | 3.7% |
| HSBC Holdings PLC (UK Reg) | 3.6% |
| Astrazeneca | 3.6% |
| Vodafone group | 2.8% |
| BHP BILLITON | 2.7% |
| Barclays | 2.2% |
| Standard Chartered | 1.9% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 06/03/2006 |
|---|---|
| Fund Manager | Michael Barakos |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.11 |
You are here: research